Download PDF
Zentralbl Gynakol 2003; 125(10): 409-414
DOI: 10.1055/s-2003-44486
Originalarbeit

© Georg Thieme Verlag Stuttgart · New York

Untersuchungen zur Regulation von CRH, ACTH und Kortisol in der Trophoblastzelle in vitro

Investigations on Regulation of CRH, ACTH and Cortisol in Trophoblast Cells in vitroI. Höcker1 , V. Briese1 , D. U. Richter1 , I. Mylonas2 , K. Friese2 , U. Jeschke2
  • 1Universität Rostock, Frauenklinik und Poliklinik, Rostock
  • 2Ludwig-Maximilians-Universität München, I. Frauenklinik-Innenstadt, München
Further Information

Publication History

Publication Date:
20 November 2003 (online)

    Permissions and Reprints

Zusammenfassung

Fragestellung: Die Trophoblastzelle synthetisiert die Peptidhormone CRH und ACTH. Durch ihre besondere enzymatische Ausstattung kann sie die Reaktion Kortisol ↔ Kortison katalysieren. In-vitro-Stimulierungsversuche an isolierten Trophoblastzellen mit CRH, ACTH und Prednisolon sollen den Einfluss auf die ACTH- und Kortisolsekretion zeigen. In einem Langzeitversuch wurde die basale Kortisolsekretionsleistung untersucht.
Methode und Methodik: Die Trophoblastzellisolierung erfolgt nach grober Präparation des Plazentagewebes mittels mehrschrittiger DNAse I und Trypsinverdauung. Die gewonnene Zellsuspension wird auf die definierte Zellkonzentration von 1 × 106 Zellen/ml eingestellt und in Nährmedium kultiviert. Nach jeweils 8 Stunden erfolgt die Zugabe von ACTH, CRH oder Prednisolon. Nach weiteren 20 bzw. 30 Minuten wird die Kortisol- bzw. ACTH-Konzentration gemessen. Parallel werden die Kortisol- bzw. ACTH-Werte einer nichtstimulierten Kultur bestimmt.
Ergebnisse: In Langzeitkulturen zeigt die Kortisolkonzentration einen rhythmischen Verlauf. Die Zugabe von CRH (500 ng/ml, 1 µg/ml) stimuliert die ACTH- und Kortisolkonzentration zeitabhängig. ACTH (500 ng/m-2 µg/ml) stimuliert die Kortisolkonzentration zeitabhängig. Prednisolon stimuliert die ACTH-Sekretion.
Schlussfolgerung: Die Trophoblastzelle weist in vitro einen rhythmischen Verlauf der Kortisolkonzentration auf. Erstmals konnte eine vollständige CRH-ACTH-Kortisol-Feedbackschleife innerhalb der Trophoblastzelle in vitro demonstriert werden.

Abstract

Objective Trophoblast cells synthesise CRH and ACTH, which are peptide hormones. On the strength of special enzymes they are capable of catalyzing the reaction cortisol ↔ cortisone. In vitro experiments should give a proof of influence to ACTH- and cortisol secretion by CRH, ACTH and prednisolon. The basal rate of cortisol secretion was examinated in a long term experiment.
Material and methods: Trophoblast cells were prepared from human term placentae by standard trypsin-DNAse dispersion of villous tissue followed by a percoll gradient centrifugation step. After adjusting the cell suspension to a defined cell concentration of 1 × 106 cells/ml the cells were cultivated. The addition of CRH, ACTH or prednisolon followed every eight hours. The samples collected 20 or 30 minutes later, also from unstimulated cultures, were assayed for ACTH and cortisol by enzyme-immunometric methods.
Results: The concentration of cortisol shows a rhythmical course in long term cell cultures. The addition of CRH (500 ng/ml, 1 µg/ml) stimulates the concentration of ACTH- and cortisol in a time-depending manner. The addition of ACTH (500 ng/ml-2 µg/ml) stimulates the concentration of cortisol in a time-depending manner. The addition of prednisolon stimulates the concentration of ACTH.
Conclusions: The trophoblast cell shows a rhythmical course in the concentration of cortisol. For the first time a CRH-ACTH-cortisol feedback loop could be demonstrated in cultured trophoblast cells.

Schlüsselwörter

Trophoblastzelle - CRH - ACTH - Kortisol - in vitro

Key words

Trophoblast cells - CRH - ACTH - cortisol - in vitro

Literatur

  • 1 Beyer H S, Matta S G, Sharp B M. Regulation of the messenger acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat.  Endocrinology. 1988;  123 2113-2117
    PubMedGoogle Scholar
  • 2 Campbell E A, Linton E A, Wolfe C DA, Scraggs P R, Jones M T, Lowry P J. Plasma corticotropin releasing hormone concentrations during pregnancy and parturition.  J Clin Endocrinol Metab. 1987;  64 1054-1059
    CrossrefPubMedGoogle Scholar
  • 3 Casey M L, Mc Donal P C. Biomolecular processes in the initiation of parturition: Decidual activation.  Clin Obstet Gynecol. 1988;  31 533-552
    PubMedGoogle Scholar
  • 4 Csapo A I. The see-saw theory of parturition.  Ciba Found Symp. 1977;  47 159-210
    PubMedGoogle Scholar
  • 5 Challis J R, Matthews S G, Van Meir C, Ramirez M M. Current topic: the placental corticotrophin- releasing hormone-adrenocorticotropin axis.  Placenta. 1995;  16 481-502
    PubMedGoogle Scholar
  • 6 Daya D, Sabet L. The use of cytokeratin as a sensitive and reliable marker for trophoblastic tissue.  Am J Clin Pathol. 1991;  95 137-141
    PubMedGoogle Scholar
  • 7 Frim D M, Emanuel R L, Robinson B G, Smas C M, Adler G K, Majzoud J A. Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta.  J Clin Invest. 1988;  82 287-291
    PubMedGoogle Scholar
  • 8 Genazzani A R, Fraioli F, Hurliman J, Felber J P. Immunoreactive ACTH and cortisol levels during pregnancy. Detection and partial purification of corticotrophin like placental hormone: the human chorionic corticotrophin (HCC).  Clin Endocrinol. 1975;  4 1-14
    PubMedGoogle Scholar
  • 9 Goland R S, Wardlaw S L, Stark R I, Frantz A G. High levels of corticotropin releasing hormone immunoreactivity in maternal and fetal plasma during pergnancy.  J Clin Endocrinol Metab. 1986;  63 1199-1203
    PubMedGoogle Scholar
  • 10 Goland R S, Wardlaw S L, Blum M, Tropper P J, Stark R I. Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy.  Am J Obst Gynecol. 1988;  159 884-890
    PubMedGoogle Scholar
  • 11 Grino M, Chrousos G P, Margioris A N. The corticotropin releasing hormone gene is expressed in human placenta.  Biochem Biophys Res Commun. 1987;  148 1208-1214
    CrossrefPubMedGoogle Scholar
  • 12 Jeschke U, Briese V, Richter D, Kunkel S. Stimulierungsversuche von Trophoblastzellen in vitro mit Hilfe von PP14.  Z Geburtsh Neonatol. 1996;  200 199-201
    PubMedGoogle Scholar
  • 13 Karalis K, Goodwin G, Majzoub J A. Cortisol blockade of progesterone: A possible molecular mechanism involved in the initiation of human labor.  Nat Med. 1996;  2 556-560
    CrossrefPubMedGoogle Scholar
  • 14 Kliman H J, Nestler J E, Sermasi E, Sanger J M, Strauss J F. Purification, Characterization, and in vitro Differentiation of Cytotrophoblasts from Human Term Placentae.  Endocrinology. 1986;  118 1567-1582
    CrossrefPubMedGoogle Scholar
  • 15 Liggins G C. Mechanisms of the onset of labor: The New Zealnd perspective.  Aust NZJ Obstet Gynaecol. 1994;  31 338-342
    PubMedGoogle Scholar
  • 16 Linton E A, Perkins A V, Woods R J, Eben F, Wolfe C D, Behan D P, Potter E, Vale W W, Lowry P J. Corticotropin releasing hormone binding protein (CRH-BP): Plasma levels decrease during the third trimester of normal human pregnancy.  J Clin Endocrinol Metab. 1993;  76 260-262
    CrossrefPubMedGoogle Scholar
  • 17 Liotta A, Houghten R, Krieger D. Identification of a β-endorphin like peptide in cultered human placental cells.  Nature. 1982;  295 593-595
    CrossrefPubMedGoogle Scholar
  • 18 McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy.  Nat Med. 1995;  1 460-463
    CrossrefPubMedGoogle Scholar
  • 19 Magiakou M A, Mastorakos G, Rabin D, Margioris A N, Dubbert B, Calogero A E, Tsigos C, Munson P J, hrousos G P. The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy.  Clin Endocrinol. 1996;  44 419-428
    CrossrefPubMedGoogle Scholar
  • 20 Osinski P A. Steroid 11β-ol dehydrogenase in human placenta.  Nature. 1960;  187 777
    PubMedGoogle Scholar
  • 21 Pepe G J, Albrecht E D. Regulation of functional differentiation of the placental villous syncytiotrophoblast by estrogen during primate pregnancy.  Steroids. 1999;  64 624-627
    CrossrefPubMedGoogle Scholar
  • 22 Petraglia F, Sawchenko P E, Rivier J, Vale W. Evidence for local stimulation of ACTH secretion by corticotropin- relreasing factor in human placenta.  Nature. 1987;  328 717-719
    CrossrefPubMedGoogle Scholar
  • 23 Petraglia F, Tabanelli S, Galassi M C, Garuti G C, Mancini A C, Genazzani A R, Gurpide E. Human decidua and in vitro decidualized endometrial stroma cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF mRNA.  J Clin Endocrinol Metab. 1992;  74 1427-1731
    CrossrefPubMedGoogle Scholar
  • 24 Petraglia F, Potter E, Camerun V, Sutton S, Behan D P, Woods R J, Sawchenko P E, Lowry P J, Vale W. Corticotropin-releasing factor binding protein is produced by human placenta and intrauterine tissues.  J Clin Endocrinol Metab. 1993;  77 919-924
    CrossrefPubMedGoogle Scholar
  • 25 Rees L, Burka C, Chard T, Evans S, Letchworth A. Possible placental origin of ACTH in normal human pregnancy.  Nature. 1975;  254 620-622
    PubMedGoogle Scholar
  • 26 Riley S C, Walton J C, Herlick J M, Challis J RG. The localization and distribution of corticotropin-releasing hormone in the human placenta and the fetal membranes throughout gestation.  J Clin Endocrinol Metab. 1991;  72 1001-1007
    PubMedGoogle Scholar
  • 27 Robinson B G, Emanuel R L, Frim D M, Majzoub J A. Glucocorticoid stimulates expression of corticotropin releasing hormone gene in human placenta.  Proc Nat Acad Sci. 1988;  85 5244-5248
    PubMedGoogle Scholar
  • 28 Sasaki A, Liotta A S, Luckey M M, Margioris A N, Suda T, Krieger D T. Immunoreactive corticotropin releasing factor is present in human maternal plasma during the third trimester of pregnancy.  J Clin Endocrinol Metab. 1984;  59 812-814
    PubMedGoogle Scholar
  • 29 Sasaki A, Osamu S, Margioris A N, Liotta A S, Sato S, Murakawi O, Go M, Shimizu Y, Hanew K, Yoshinaga K. Immunoreactive corticotropin-releasing hormone in human palsma during pregnancy, labor, and delivery.  J Clin Endocrinol Metab. 1987;  64 224-229
    CrossrefPubMedGoogle Scholar
  • 30 Sasaki A, Tempst P, Liotta A S, Margoiris A N, Hood L E, Kent S B, Sato S, Shinkawa O, Yoshinaga K, Krieger D T. Isolation and characterization of a corticotropin-releasing hormone-like peptide from human placenta.  J Clin Endorinol Metab. 1988;  67 768-773
    PubMedGoogle Scholar
  • 31 Seckl J R. Glucocorticoids ans small babies.  QJ Med. 1994;  87 259-262
    PubMedGoogle Scholar
  • 32 Shibasaki T, Odagiri E, Shizume K, Ling N. Corticotropin-releasing factor-like activity in human placental extracts.  J Clin Endocrinol Metab. 1982;  55 384-386
    PubMedGoogle Scholar
  • 33 Smith R, Thomson M. Neuroendocrinology of the hypothalamo-pituitary-adrenal axis in pregnancy and the puerperium.  Bailliere's Clin Endocrinol Metab. 1991;  5 167-188
    PubMedGoogle Scholar
  • 34 Stalla G K, Bost H, Stalla T, Kaliebe H G, Dörr D, Pfeiffer D, von Werder K, Müller O A. Human corticotropin releasing hormone during pregnancy.  Gynecol Endocrinol. 1989;  3 1-10
    PubMedGoogle Scholar
  • 35 Stewart P M, Rogerson F M, Mason J I. Type 2 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes:ist relationship to birth weight and putative role in fetal adrenal steroidogenesis.  J Clin Endocrinol Metab. 1995;  80 885-890
    CrossrefPubMedGoogle Scholar
  • 36 Sun K, Yang K, Challis J RG. Glucocorticoid actions and metabolisms in pregnancy: Implications for placental function and fetal cardiovascular activity.  Placenta. 1998;  19 353-360
    CrossrefPubMedGoogle Scholar
  • 37 Tulchinsky D, Hobel C J, Yeager E, Marshall J R. Plasma estrone, estradiol, progesterone and 17-hydroxyprogesterone in human pregnancy.  Am J Obstet Gynecol. 1972;  112 1095-1100
    PubMedGoogle Scholar
  • 38 Warren W B, Silverman A J. Cellular localization of corticotropin releasing hormone in the placenta, fetal membranes and deciduas.  Placenta. 1995;  16 147-156
    CrossrefPubMedGoogle Scholar

Dr. rer. nat. habil. U Jeschke

I. Frauenklinik - Klinikum Innenstadt

Ludwig-Maximilians-Universität München

Maistraße 11

80337 München

Deutschland

Phone: +49/89-51 60-42 66

Fax: +49/89-51 60-49 16

Email: udo.jeschke@fk-i.med.uni-muenchen.de

      >